You are here:

Archived: Pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®)

Advice

Following a resubmission

Pregabalin (Lyrica®) is not recommended for use within NHS Scotland for the treatment of peripheral neuropathic pain in adults.

Clinical and cost effectiveness have not been demonstrated and the economic case for use in patients refractory to other treatments has also not been demonstrated.

Drug Details

Drug Name: Pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®)
SMC Drug ID: 157/05
Manufacturer: Pfizer Ltd
Indication: Peripheral neuropathic pain
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Resubmission
Status: Not Recommended
Date Advice Published: 15 August 2005

Current Advice

Resubmission 11 May 2009

Archived Advice

IRP 7 August 2006
Full submission 7 March 2005

Back